Skip to main navigation Skip to search Skip to main content

Fibrosis Entropy Is Associated With Life-Threatening Arrhythmia in Nonischemic Cardiomyopathy

  • Daniel J. Hammersley
  • , Hassan A. Zaidi
  • , Richard E. Jones
  • , Suzan Hatipoglu
  • , Emmanuel Androulakis
  • , Gabriel Balaban
  • , Lukas Mach
  • , Amrit S. Lota
  • , Zohya Khalique
  • , Antonio De Marvao
  • , Aleksandra Lopuszko
  • , Laura Lazzari
  • , Andrew Ravendren
  • , Ankur Gulati
  • , Resham Baruah
  • , Kaushik Guha
  • , Upasana Tayal
  • , Francisco Leyva
  • , A. John Baksi
  • , James S. Ware
  • Pablo Lamata, Dudley J. Pennell, Brian P. Halliday, Martin J. Bishop, Sanjay K. Prasad
  • Lewisham and Greenwich NHS Trust, London, United Kingdom
  • Clinical Neurophysiology, Portsmouth Hospitals NHS Trust, United Kingdom

Research output: Contribution to journalArticlepeer-review

5 Downloads (Pure)

Abstract

BACKGROUND: Greater precision is required for arrhythmic risk stratification of patients with nonischemic cardiomyopathy (NICM). We sought to evaluate whether fibrosis entropy, a measure of scar texture heterogeneity derived from late gadolinium enhancement cardiovascular magnetic resonance, has incremental utility to fibrosis presence for arrhythmic risk prediction in NICM.

METHODS: In this prospective observational cohort study, fibrosis entropy was calculated for patients with NICM and fibrosis (late gadolinium enhancement positive, LGE+), including regions of core fibrosis, gray zone fibrosis and combined core and gray zone fibrosis. Patients with NICM and no fibrosis (LGE-) were included as a comparator group. Adjudicated follow-up for life-threatening arrhythmia included sudden cardiac death, aborted sudden cardiac death, or sustained ventricular tachycardia.

RESULTS: Of 291 patients with LGE+ NICM, 38 (13.1%) experienced life-threatening arrhythmia over a median follow-up of 6.3 years. Core fibrosis entropy (per-SD hazard ratio [HR], 1.77 [95% CI, 1.25-2.52]; P=0.001), gray zone fibrosis entropy (HR, 1.97 [95% CI, 1.20-2.54]; P=0.004), and combined fibrosis entropy (HR, 1.98 [95% CI, 1.30-3.02]; P=0.004) were each associated with life-threatening arrhythmia after adjustment for variables used to determine implantable cardioverter-defibrillator candidacy in clinical practice (left ventricular ejection fraction ≤35% and New York Heart Association class >1) and remained associated after accounting for core and gray zone fibrosis mass. Left ventricular ejection fraction ≤35% was not associated with life-threatening arrhythmia (HR, 1.45 [95% CI, 0.77-2.74]; P=0.250). Integration of fibrosis presence with fibrosis entropy classified patients into low-, intermediate-, and high-arrhythmic-risk groups.

CONCLUSIONS: Deeper phenotypic characterization of scar using fibrosis entropy offers incremental utility to left ventricular ejection fraction and fibrosis presence for arrhythmic risk stratification in NICM.

Original languageEnglish
Article numbere040517
Number of pages11
JournalJournal of the American Heart Association
Volume14
Issue number18
Early online date11 Sept 2025
DOIs
Publication statusPublished - 16 Sept 2025

Bibliographical note

Copyright © 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Funding

This work was supported by: NHLF Royston Centre for Cardiomyopathy grant awarded to S.K.P., D.J.H., R.E.J., U.T., and B.P.H.; The British Heart Foundation (FS/ICRF/21/26019; RE/18/4/34215; SP/17/11/32885); EPSRC 2018/19 DTP—EP/R513064/1 grant; the National Institute for Health Research Biomedical Research Centre at Guy’s and St. Thomas’ Trust and King’s College, the Centre of Excellence in Medical Engineering funded by the Wellcome Trust and Engineering and Physical Sciences; Research Council (EPSRC; WT088641/Z/09/Z); Rosetrees Trust; Alexander Jansons Myocarditis UK Foundation; Royston Centre for Cardiomyopathy Research; Sir Jules Thorn Charitable Trust (21JTA); National Institute for Health Research Royal Brompton Cardiovascular Biomedical Research Unit; National Institute for Health Research Imperial College Biomedical Research Centre; P.L. holds a Wellcome Trust Senior Research Fellowship (209 450/Z/17/Z); H.Z. acknowledges EPSRC 2018/19 DTP-EP/R513064/1 grant; M.J.B., S.K.P., and B.P.H. acknowledge the BHF through project grant PG/22/11159.

Keywords

  • entropy
  • Female
  • Risk Factors
  • fibrosis
  • Fibrosis
  • Arrhythmias, Cardiac - etiology - diagnosis - physiopathology
  • nonischemic cardiomyopathy
  • Prospective Studies
  • Entropy
  • Male
  • Aged
  • Cardiomyopathies - complications - physiopathology - pathology - diagnostic imaging
  • Magnetic Resonance Imaging, Cine - methods
  • Myocardium - pathology
  • Humans
  • Risk Assessment
  • arrhythmic risk stratification
  • Middle Aged

Fingerprint

Dive into the research topics of 'Fibrosis Entropy Is Associated With Life-Threatening Arrhythmia in Nonischemic Cardiomyopathy'. Together they form a unique fingerprint.

Cite this